Huo Luo Pain Relieving

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 3 years and older, the recommended dosage is to apply several drops of the product to the affected area and rub it in gently. This application may be performed up to 3 to 4 times daily, ensuring that the total number of applications does not exceed this frequency.

For children under 3 years of age, it is advised to consult a physician prior to use to determine the appropriate course of action.

Contraindications

The product is contraindicated in the following situations:

Use is not recommended on wounds or on irritated or damaged skin due to the potential for exacerbating the condition and causing further injury. Additionally, the product should not be used otherwise than as directed, and contact with the eyes or mucous membranes must be avoided to prevent irritation. Tight bandaging is contraindicated, as it may lead to compromised circulation. The application of heat, such as heating pads, hot water bottles, or lamps, is also contraindicated due to the increased risk of serious burns.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

General precautions must be observed to ensure safe usage. This product should not be applied to wounds or on irritated or damaged skin, as this may exacerbate the condition or lead to adverse effects.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: the condition worsens; symptoms persist for more than 7 days; symptoms resolve and then recur within a few days; excessive skin irritation develops; gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, or skin rash manifest; or if the patient experiences actual pain, blistering, or burning after application. It is important to note that a warming or cooling sensation is expected and not a cause for concern.

In cases where the product is used for arthritis-related pain, patients should be instructed to seek medical advice if pain persists for more than 10 days, if redness is observed, or if the patient is under 12 years of age.

Emergency medical help should be sought immediately if the product is swallowed, and contacting a Poison Control Center is strongly recommended in such instances.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious adverse reactions may necessitate discontinuation of use and consultation with a healthcare professional. Patients are advised to stop use and seek medical advice if any of the following occur: worsening of the condition, persistence of symptoms for more than 7 days, recurrence of symptoms after initial improvement within a few days, excessive skin irritation, or the onset of nausea, vomiting, abdominal discomfort, diarrhea, or skin rash.

Additionally, if patients experience actual pain, blistering, or burning after application—beyond the expected warming or cooling sensation—they should discontinue use and consult a doctor. For those using the product for arthritis-related pain, it is particularly important to seek medical advice if pain persists for more than 10 days, if redness is present, or if the product is being used in children under 12 years of age.

This product is intended for external use only.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Huo Luo Pain Relieving (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 3 years of age should consult a physician before use. For adults and children aged 3 years and older, the recommended application is several drops rubbed into the affected area no more than 3 to 4 times daily.

In cases of arthritis pain in children under 12 years of age, if pain persists for more than 10 days or if redness is present, use should be discontinued and a doctor should be consulted.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

The product has not been evaluated for safety in pregnant women. While there are no specific contraindications stated, caution is advised as the product is intended for external use only. There are no specific warnings or precautions regarding the use of this product during pregnancy. Additionally, no dosage modifications are provided for pregnant individuals, and no special precautions concerning pregnancy are mentioned in the prescribing information. Healthcare professionals should consider the lack of safety data when advising pregnant patients about the use of this product.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include alterations in consciousness, respiratory distress, cardiovascular instability, and other systemic effects.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and clinical status, and initiate supportive care as necessary. It is crucial to gather a detailed history of the substance involved, including the amount and route of administration, to guide further management.

Management procedures may include the administration of activated charcoal if the patient presents within a suitable timeframe and is not at risk for aspiration. In cases of severe toxicity, specific antidotes may be indicated, and consultation with a poison control center or a medical toxicologist is advised.

Continuous monitoring of the patient’s clinical status is essential, and supportive measures should be implemented as needed. Documentation of the incident and the management provided is also critical for ongoing care and future reference.

In summary, while no specific overdosage information is available, healthcare professionals should be prepared to respond promptly and effectively to any suspected cases of overdose, ensuring patient safety and optimal outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Reports of unexpected side effects associated with the use of this product have been received through voluntary submissions and surveillance programs. Healthcare professionals and consumers are encouraged to report any adverse events to the FDA MedWatch Program. Serious side effects can also be reported directly by calling 888-221-3496, available Monday through Friday from 9 am to 5 pm.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed not to use the product on wounds or on irritated or damaged skin. It is important to inform patients to discontinue use and consult a doctor if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, excessive skin irritation develops, or if they experience nausea, vomiting, abdominal discomfort, diarrhea, or a skin rash. Additionally, patients should seek medical advice if they feel actual pain or experience blistering or burning after application, noting that a warming or cooling sensation is expected.

For those using the product for arthritis pain, patients should be advised to stop use and consult a doctor if pain persists for more than 10 days, if redness is present, or if the product is being used for conditions affecting children under 12 years of age.

When using this product, patients should be reminded to follow the directions carefully and avoid using it in any manner other than as directed. They should also avoid contact with the eyes or mucous membranes, refrain from tightly bandaging the area, and not apply heat in the form of heating pads, hot water bottles, or lamps, as this may increase the risk of serious burns.

Finally, patients should be encouraged to consult a doctor or pharmacist if they have any concerns regarding the use of this product.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored protected from light within a temperature range of 15 to 30°C (59 to 86°F) to ensure optimal stability and efficacy.

Additional Clinical Information

The medication is administered topically. For adults and children aged 3 years and older, several drops should be applied and rubbed into the affected area no more than 3 to 4 times daily. For children under 3 years of age, it is advised to consult a physician prior to use.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Huo Luo Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)